| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |